Research Article
Fabrication, Characterization, and In Vivo Evaluation of Famotidine Loaded Solid Lipid Nanoparticles for Boosting Oral Bioavailability
Table 1
Formulations of unloaded SLNs.
| | Formulation | Stearic acid (g) | Tween-80 (ml) | PVP (g) | Stirring time (min) |
| | UFSe-1 | 1.00 | 0.5 | Nil | 5 | | UFSe-2 | 1.00 | 1 | Nil | 5 | | UFSe-3 | 1.00 | 1.5 | Nil | 5 | | UFSe-4 | 1.00 | 2 | Nil | 5 | | UFSe-5 | 1.00 | 1.9 | 0.1 | 5 | | UFSe-6 | 1.00 | 1.8 | 0.2 | 5 | | UFSe-7 | 1.00 | 1.7 | 0.3 | 5 | | UFSe-8 | 1.00 | 1.6 | 0.4 | 5 | | UFSe-9 | 1.00 | 1.5 | 0.5 | 5 | | UFSe-10 | 1.00 | 1.6 | 0.4 | 10 | | UFSe-11 | 1.00 | 1.6 | 0.4 | 15 | | UFSe-12 | 1.00 | 1.6 | 0.4 | 20 |
|
|
PVP: polyvinyl pyrrolidone.
|
